Key result
Selective iNOS blockade by N-(3-(aminomethyl)benzylacetamidine improved attenuated beta-adrenergic responsiveness in rats with volume-overload heart failure.
Why the study?
Does selective iNOS blockade improve depressed myocardial contractility and beta-adrenergic hyporesponsiveness in rats with volume-overload heart failure?
Population
Rats with volume-overload-induced heart failure, divided into compensated and decompensated subgroups based…
Comparison
Selective iNOS blockade by N-(3-benzylacetamidine vs Control rats and heart failure rats without iNOS…
Design
Preclinical
Authors
Loading...
iNOS activation may impair contractility in experimental volume-overload HF; leaves open its role and therapeutic targeting in patients.
Does selective iNOS blockade improve depressed myocardial contractility and beta-adrenergic hyporesponsiveness in rats with volume-overload heart failure?
Myocardial iNOS is activated in volume-overload heart failure and its selective blockade improves depressed beta-adrenergic responsiveness.
Gealekman et al. (2002) studied Volume-overload heart failure. Selective iNOS blockade by N-(3-(aminomethyl)benzylacetamidine vs. Controls / unblocked HF rats was evaluated on Beta-adrenergic responsiveness and myocardial contractility. Selective iNOS blockade by N-(3-(aminomethyl)benzylacetamidine improved attenuated beta-adrenergic responsiveness in rats with volume-overload heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: